title: Pazopanib in metastatic osteosarcoma: significant clinical response in three consecutive patients.
authors.affiliation: Department of Oncology, Aarhus University Hospital , Aarhus , Denmark.
authors.forename: Akmal
authors.initials: A
authors.lastname: Safwat
authors.forename: Anders
authors.initials: A
authors.lastname: Boysen
authors.forename: Arne
authors.initials: A
authors.lastname: Lücke
authors.forename: Philip
authors.initials: P
authors.lastname: Rossen
mesh_terms: D000293:Adolescent; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D006811:Humerus; D007191:Indazoles; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000188:drug therapy*; D012516:Osteosarcoma / Q000188:drug therapy* / Q000556:secondary; D011743:Pyrimidines / Q000008:administration & dosage*; D012888:Skull Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage*; D055815:Young Adult
chemical_list: D020533:Angiogenesis Inhibitors; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib